Re: Lepore et al.: Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings (Ophthalmology 2014;121:2212-9)
- PMID: 26210602
- DOI: 10.1016/j.ophtha.2014.11.031
Re: Lepore et al.: Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings (Ophthalmology 2014;121:2212-9)
Comment in
-
Author reply: To PMID 25001158.Ophthalmology. 2015 Aug;122(8):e49-50. doi: 10.1016/j.ophtha.2015.02.018. Ophthalmology. 2015. PMID: 26210603 No abstract available.
Comment on
-
Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings.Ophthalmology. 2014 Nov;121(11):2212-9. doi: 10.1016/j.ophtha.2014.05.015. Epub 2014 Jul 4. Ophthalmology. 2014. PMID: 25001158 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
